“My goal is to create tools for non-invasive risk prediction [for cancer].”
Natasha Sheybani, PhD, serves as a Senior Scientist at the Focused Ultrasound Foundation, where her role involves supporting research programs in glioblastoma, gene therapy and cancer immunotherapy. She is also a Postdoctoral Research Fellow at Stanford University, where her appointment is shared among the Departments of Oncology, Radiology, and Biomedical Data Science.
Her research focuses on applications of liquid biopsy and radiomics/radiogenomics for advancing precision immuno-oncology. Sheybani received her BS (2015) and PhD (2020) in Biomedical Engineering from Virginia Commonwealth University and University of Virginia (UVA), respectively. Her graduate research at UVA centered on leveraging image-guided focused ultrasound to potentiate immunotherapy for solid tumors including glioblastoma and metastatic breast cancer. During her training, Sheybani was supported by the NSF Graduate Research Fellowship and Robert R. Wagner Fellowship, and she currently holds the prestigious NCI F99/K00 Predoctoral to Postdoctoral Fellow Transition Award.